Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma

Pingfang Song, Harmanjatinder S. Sekhon, Yibing Jia, Jennifer A. Keller, Jan Krzysztof Blusztajn, Gregory Mark, Eliot Spindel

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

It is well established that small cell lung carcinomas (SCLCs) express receptors for acetylcholine (ACh) and that stimulation of these receptors by nicotine or other cholinergic agonists stimulates cell growth via activation of nicotinic cholinergic receptors (nAChRs) and/or muscarinic cholinergic receptors (mAChRs). The aim of this study was to determine whether SCLC cells synthesize and secrete ACh and respond to endogenous ACh to create a functioning cholinergic autocrine loop. Reverse transcription-PCR was used to screen a panel of SCLC cell lines for components of cholinergic signaling. Choline acetyltransferase (ChAT) and the vesicular ACh transporter (VAChT), as well as α3, α5, α7, β2, and β4, nAChR subunits and M3 and M5 mAChRs, were found to be present in most of the SCLC cell lines tested. Real-time PCR showed that mRNA levels for ChAT, VAChT, and α7 and β2 nAChR subunits varied significantly among different SCLC cell lines tested. The H82 cell line was found to express the highest levels of ChAT, and that cell line was chosen for additional studies of ACh release and cell proliferation. ACh was easily detectable in H82 cell culture media, and levels of ACh were increased by the acetylcholinesterase inhibitor neostigmine. Vesamicol, an inhibitor of VAChT, and hemicholinium-3, an inhibitor of choline transport, both reduced H82 cell ACh basal release in a dose-dependent manner. In parallel with the reductions of ACh release, vesamicol and hemicholinium-3 also decreased H82 cell proliferation. H82 cell proliferation was also inhibited by the muscarinic and nicotinic antagonists atropine and mecamylamine, respectively, in dose- and time-dependent manners. Finally, archival cases of SCLC were screened by immunohistochemistry for expression of ChAT. Thirteen of 26 tumors screened were positive for ChAT. These findings demonstrate that SCLC can synthesize, secrete, and degrade ACh and that released ACh stimulates SCLC cell growth. Identification of this new autocrine loop provides a potential new target for therapeutic intervention.

Original languageEnglish (US)
Pages (from-to)214-221
Number of pages8
JournalCancer Research
Volume63
Issue number1
StatePublished - Jan 1 2003

Fingerprint

Small Cell Lung Carcinoma
Acetylcholine
Intercellular Signaling Peptides and Proteins
Choline O-Acetyltransferase
Cholinergic Receptors
Cell Line
Hemicholinium 3
Cell Proliferation
Muscarinic Receptors
Cholinergic Agents
Vesicular Acetylcholine Transport Proteins
Nicotinic Antagonists
Mecamylamine
Neostigmine
Cholinergic Agonists
Muscarinic Antagonists
Cholinesterase Inhibitors
Nicotinic Receptors
Cellular Structures
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Song, P., Sekhon, H. S., Jia, Y., Keller, J. A., Blusztajn, J. K., Mark, G., & Spindel, E. (2003). Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Research, 63(1), 214-221.

Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. / Song, Pingfang; Sekhon, Harmanjatinder S.; Jia, Yibing; Keller, Jennifer A.; Blusztajn, Jan Krzysztof; Mark, Gregory; Spindel, Eliot.

In: Cancer Research, Vol. 63, No. 1, 01.01.2003, p. 214-221.

Research output: Contribution to journalArticle

Song, P, Sekhon, HS, Jia, Y, Keller, JA, Blusztajn, JK, Mark, G & Spindel, E 2003, 'Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma', Cancer Research, vol. 63, no. 1, pp. 214-221.
Song P, Sekhon HS, Jia Y, Keller JA, Blusztajn JK, Mark G et al. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Research. 2003 Jan 1;63(1):214-221.
Song, Pingfang ; Sekhon, Harmanjatinder S. ; Jia, Yibing ; Keller, Jennifer A. ; Blusztajn, Jan Krzysztof ; Mark, Gregory ; Spindel, Eliot. / Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. In: Cancer Research. 2003 ; Vol. 63, No. 1. pp. 214-221.
@article{ab8396d3e7224b7a89f1bf26f7f399ab,
title = "Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma",
abstract = "It is well established that small cell lung carcinomas (SCLCs) express receptors for acetylcholine (ACh) and that stimulation of these receptors by nicotine or other cholinergic agonists stimulates cell growth via activation of nicotinic cholinergic receptors (nAChRs) and/or muscarinic cholinergic receptors (mAChRs). The aim of this study was to determine whether SCLC cells synthesize and secrete ACh and respond to endogenous ACh to create a functioning cholinergic autocrine loop. Reverse transcription-PCR was used to screen a panel of SCLC cell lines for components of cholinergic signaling. Choline acetyltransferase (ChAT) and the vesicular ACh transporter (VAChT), as well as α3, α5, α7, β2, and β4, nAChR subunits and M3 and M5 mAChRs, were found to be present in most of the SCLC cell lines tested. Real-time PCR showed that mRNA levels for ChAT, VAChT, and α7 and β2 nAChR subunits varied significantly among different SCLC cell lines tested. The H82 cell line was found to express the highest levels of ChAT, and that cell line was chosen for additional studies of ACh release and cell proliferation. ACh was easily detectable in H82 cell culture media, and levels of ACh were increased by the acetylcholinesterase inhibitor neostigmine. Vesamicol, an inhibitor of VAChT, and hemicholinium-3, an inhibitor of choline transport, both reduced H82 cell ACh basal release in a dose-dependent manner. In parallel with the reductions of ACh release, vesamicol and hemicholinium-3 also decreased H82 cell proliferation. H82 cell proliferation was also inhibited by the muscarinic and nicotinic antagonists atropine and mecamylamine, respectively, in dose- and time-dependent manners. Finally, archival cases of SCLC were screened by immunohistochemistry for expression of ChAT. Thirteen of 26 tumors screened were positive for ChAT. These findings demonstrate that SCLC can synthesize, secrete, and degrade ACh and that released ACh stimulates SCLC cell growth. Identification of this new autocrine loop provides a potential new target for therapeutic intervention.",
author = "Pingfang Song and Sekhon, {Harmanjatinder S.} and Yibing Jia and Keller, {Jennifer A.} and Blusztajn, {Jan Krzysztof} and Gregory Mark and Eliot Spindel",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
volume = "63",
pages = "214--221",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma

AU - Song, Pingfang

AU - Sekhon, Harmanjatinder S.

AU - Jia, Yibing

AU - Keller, Jennifer A.

AU - Blusztajn, Jan Krzysztof

AU - Mark, Gregory

AU - Spindel, Eliot

PY - 2003/1/1

Y1 - 2003/1/1

N2 - It is well established that small cell lung carcinomas (SCLCs) express receptors for acetylcholine (ACh) and that stimulation of these receptors by nicotine or other cholinergic agonists stimulates cell growth via activation of nicotinic cholinergic receptors (nAChRs) and/or muscarinic cholinergic receptors (mAChRs). The aim of this study was to determine whether SCLC cells synthesize and secrete ACh and respond to endogenous ACh to create a functioning cholinergic autocrine loop. Reverse transcription-PCR was used to screen a panel of SCLC cell lines for components of cholinergic signaling. Choline acetyltransferase (ChAT) and the vesicular ACh transporter (VAChT), as well as α3, α5, α7, β2, and β4, nAChR subunits and M3 and M5 mAChRs, were found to be present in most of the SCLC cell lines tested. Real-time PCR showed that mRNA levels for ChAT, VAChT, and α7 and β2 nAChR subunits varied significantly among different SCLC cell lines tested. The H82 cell line was found to express the highest levels of ChAT, and that cell line was chosen for additional studies of ACh release and cell proliferation. ACh was easily detectable in H82 cell culture media, and levels of ACh were increased by the acetylcholinesterase inhibitor neostigmine. Vesamicol, an inhibitor of VAChT, and hemicholinium-3, an inhibitor of choline transport, both reduced H82 cell ACh basal release in a dose-dependent manner. In parallel with the reductions of ACh release, vesamicol and hemicholinium-3 also decreased H82 cell proliferation. H82 cell proliferation was also inhibited by the muscarinic and nicotinic antagonists atropine and mecamylamine, respectively, in dose- and time-dependent manners. Finally, archival cases of SCLC were screened by immunohistochemistry for expression of ChAT. Thirteen of 26 tumors screened were positive for ChAT. These findings demonstrate that SCLC can synthesize, secrete, and degrade ACh and that released ACh stimulates SCLC cell growth. Identification of this new autocrine loop provides a potential new target for therapeutic intervention.

AB - It is well established that small cell lung carcinomas (SCLCs) express receptors for acetylcholine (ACh) and that stimulation of these receptors by nicotine or other cholinergic agonists stimulates cell growth via activation of nicotinic cholinergic receptors (nAChRs) and/or muscarinic cholinergic receptors (mAChRs). The aim of this study was to determine whether SCLC cells synthesize and secrete ACh and respond to endogenous ACh to create a functioning cholinergic autocrine loop. Reverse transcription-PCR was used to screen a panel of SCLC cell lines for components of cholinergic signaling. Choline acetyltransferase (ChAT) and the vesicular ACh transporter (VAChT), as well as α3, α5, α7, β2, and β4, nAChR subunits and M3 and M5 mAChRs, were found to be present in most of the SCLC cell lines tested. Real-time PCR showed that mRNA levels for ChAT, VAChT, and α7 and β2 nAChR subunits varied significantly among different SCLC cell lines tested. The H82 cell line was found to express the highest levels of ChAT, and that cell line was chosen for additional studies of ACh release and cell proliferation. ACh was easily detectable in H82 cell culture media, and levels of ACh were increased by the acetylcholinesterase inhibitor neostigmine. Vesamicol, an inhibitor of VAChT, and hemicholinium-3, an inhibitor of choline transport, both reduced H82 cell ACh basal release in a dose-dependent manner. In parallel with the reductions of ACh release, vesamicol and hemicholinium-3 also decreased H82 cell proliferation. H82 cell proliferation was also inhibited by the muscarinic and nicotinic antagonists atropine and mecamylamine, respectively, in dose- and time-dependent manners. Finally, archival cases of SCLC were screened by immunohistochemistry for expression of ChAT. Thirteen of 26 tumors screened were positive for ChAT. These findings demonstrate that SCLC can synthesize, secrete, and degrade ACh and that released ACh stimulates SCLC cell growth. Identification of this new autocrine loop provides a potential new target for therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=0037229715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037229715&partnerID=8YFLogxK

M3 - Article

C2 - 12517800

AN - SCOPUS:0037229715

VL - 63

SP - 214

EP - 221

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -